Opendata, web and dolomites
H2020 projects about "chimeric"
The page lists 36 projects related to the topic "chimeric".
| # | |||
|---|---|---|---|
| 1 | COMPUCELL | Autonomous Cellular Computers for Diagnosis | 2015 |
| 2 | CARiPSCTcells | Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application | 2015 |
| 3 | ROR2BONE | Investigating Ror2-dependent non-canonical Wnt signaling in bone remodeling | 2015 |
| 4 | HBV1 | Innate immune responses to human hepatotropic viral infections | 2015 |
| 5 | FLYghtCaRe | Ca2+ feedback control of TRP/TRPL channels in Drosophila photoreceptors | 2015 |
| 6 | CerviVax | New Generation Therapeutic vaccine for the Treatment of HPV infections and Cervical Dysplasia | 2015 |
| 7 | CARAT | Chimeric Antigen Receptors (CARs) for Advanced Therapies | 2016 |
| 8 | TARG-SUP | Targeting TGF-β activation, likely the core mechanism of immunosuppression by human regulatory T cells. | 2016 |
| 9 | MCNTMTDC | Metabolic control on NF-κB activity during dendritic cells-mediated immune tolerance to tumours | 2017 |
| 10 | BoostR | Engineering disease resistance gene networks: synthetic helpers for expanded sensors | 2016 |
| 11 | RABYD-VAX | Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine | 2017 |
| 12 | EURE-CART | EURopean Endeavour for Chimeric Antigen Receptor Therapies | 2017 |
| 13 | EVOLVE | Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy | 2017 |
| 14 | FusionPAMPs | New generation of chimeric TLR2-NOD agonist compounds for vaccine adjuvants | 2017 |
| 15 | GREEN-SPECIALISTS | Specialised plant cell types via developmentally-controlled gene knockouts: a key step towards fully customised plants | 2018 |
| 16 | EwiSarc | A novel in vivo platform to study and target undruggable Ewing onco-chimera. | 2017 |
| 17 | CAR ART | Chimeric Antigen Receptor to generate Alloantigen-specific Regulatory T cells and promote allograft tolerance | 2017 |
| 18 | VDJtargeting | Engineering T cells and B cells for Immunotherapy using V(D)J recombination | 2017 |
| 19 | CELLNAIVETY | Deciphering the Molecular Foundations and Functional Competence of Alternative Human Naïve Pluripotent Stem Cells | 2017 |
| 20 | 5D Heart Patch | A Functional, Mature In vivo Human Ventricular Muscle Patch for Cardiomyopathy | 2017 |
| 21 | ANTIViR | Molecular mechanisms of interferon-induced antiviral restriction and signalling | 2017 |
| 22 | InTheMLLrBALL | Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia | 2018 |
| 23 | MATURE-NK | MAnufacturing of TUmour-REactive Natural Killer cells | 2018 |
| 24 | CARAMBA | SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease | 2018 |
| 25 | BIOCARD | Deep BIOmodeling of human CARDiogenesis | 2018 |
| 26 | GRASP | Overcoming plant graft incompatibility by modifying signalling and perception | 2019 |
| 27 | Lakhesys | Lakhesys: building the machine to make the medicines of tomorrow | 2019 |
| 28 | Exh-Res-CART | Exhaustion-resistant CAR-T cells for the treatment of solid tumours | 2019 |
| 29 | CRUZIVAX | Vaccine for prevention and treatment of Trypanosoma cruzi infection | 2019 |
| 30 | Recruit | Origin and Function of Tumor-Associated Macrophages and Mesenchymal Stromal Cells in GBM Subtypes | 2019 |
| 31 | HARNESS | Harnessing experimental evolution of rhizobia for an integrative view of endosymbiosis | 2019 |
| 32 | PLAMORF | Plant Mobile RNAs: Function, Transport and Features | 2019 |
| 33 | CELLPHASE_AD | Genetics to understand cellular components of Alzheimer Disease pathogenesis | 2019 |
| 34 | PANDORA | Pandemics Outbreaks Rationalized: towards a universal therapy to eliminate intracellular pathogens and drug resistance | 2020 |
| 35 | Glue2Degrade | Therapeutic hijacking of E3 Ligases | 2020 |
| 36 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |